Prasugrel: A Novel Antiplatelet Therapy for Acute Coronary Syndromes

E-ISSN： 2212-3962|4|3|192-202

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.4, Iss.3, 2009-11, pp. : 192-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Antiplatelet Therapy in Acute Coronary Syndromes: What is New in the Pipeline?

Current Vascular Pharmacology, Vol. 10, Iss. 5, 2012-09 ,pp. : 606-618

Bentham Science Publishers

Access to resources Recommend Favorite

Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review

Current Cardiology Reviews, Vol. 13, Iss. 4, 2017-10 ,pp. : 325-333

Bentham Science Publishers

Access to resources Recommend Favorite

Personalized antiplatelet therapy in acute coronary syndromes: a dead-end street or a future scenario?

By Marcucci Rossella Giusti Betti Abbate Rosanna

Interventional Cardiology, Vol. 5, Iss. 6, 2013-12 ,pp. : 601-604

Future Medicine

Access to resources Recommend Favorite

Anticoagulant therapy in acute coronary syndromes

By Bates Eric R

Future Cardiology, Vol. 3, Iss. 3, 2007-05 ,pp. : 301-308

Future Medicine

Access to resources Recommend Favorite

Current Status of Antiplatelet Therapy in Acute Coronary Syndrome

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 13, Iss. 1, 2015-01 ,pp. : 40-49

Bentham Science Publishers

Access to resources Recommend Favorite